Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
The importance of platelet activation during hemostasis is well understood. An understanding of these mechanisms has led to the use of several classes of anti-platelet drugs to inhibit aggregation for the prevention of thrombi during cardiovascular disease. It is now also recognized that platelets c...
Main Authors: | Sajeel A. Shah, Clive P. Page, Simon C. Pitchford |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00129/full |
Similar Items
-
Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients
by: Maged Mohamed Refaat, et al.
Published: (2022-10-01) -
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
by: Christian Lupinek, et al.
Published: (2017-03-01) -
Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
by: Andrea Matucci, et al.
Published: (2018-06-01) -
Relationship between longitudinal changes in type‐2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics
by: Nikolaos Tsolakis, et al.
Published: (2021-09-01) -
Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease
by: Chapman Richard W, et al.
Published: (2001-03-01)